We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

103 hedge funds and large institutions have $269M invested in Albany Molecular Research Inc in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

18% more capital invested

Capital invested by funds: $228M → $269M (+$40.6M)

16% more call options, than puts

Call options by funds: $501K | Put options by funds: $433K

5% more funds holding

Funds holding: 98103 (+5)

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

Holders
103
Holders Change
+5
Holders Change %
+5.1%
% of All Funds
3.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
36
Reduced
35
Closed
13
Calls
$501K
Puts
$433K
Net Calls
+$68K
Net Calls Change
+$378K
Name Holding Trade Value Shares
Change
Change in
Stake
HK
51
Horizon Kinetics
New York
$722K
Asset Management One
52
Asset Management One
Japan
$638K +$608K +49,465 New
FQ
53
First Quadrant
California
$589K +$562K +45,700 New
American Century Companies
54
American Century Companies
Missouri
$549K +$524K +42,561 New
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$537K +$13.5K +1,100 +3%
JP Morgan Chase
56
JP Morgan Chase
New York
$488K +$216K +17,539 +86%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$474K -$2.52K -205 -0.6%
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$447K +$7.31K +594 +2%
CIC
59
Cornercap Investment Counsel
Georgia
$445K +$424K +34,485 New
Wells Fargo
60
Wells Fargo
California
$427K +$390K +31,671 +2,134%
TA
61
Teachers Advisors
New York
$420K +$23.9K +1,943 +6%
HCM
62
Highbridge Capital Management
New York
$408K -$1.69M -137,540 -81%
PCM
63
Prelude Capital Management
New York
$387K
SIM
64
Spark Investment Management
New York
$383K -$389K -31,600 -51%
Deutsche Bank
65
Deutsche Bank
Germany
$371K +$161K +13,101 +83%
HIM
66
Hillsdale Investment Management
Ontario, Canada
$343K
KeyBank National Association
67
KeyBank National Association
Ohio
$335K
First Trust Advisors
68
First Trust Advisors
Illinois
$334K -$210K -17,043 -40%
ProShare Advisors
69
ProShare Advisors
Maryland
$333K +$318K +25,867 New
SCM
70
Sterling Capital Management
North Carolina
$305K +$291K +23,661 New
OSAM
71
O'Shaughnessy Asset Management
Connecticut
$295K -$5.41K -440 -2%
OTPPB
72
Ontario Teachers' Pension Plan Board
Ontario, Canada
$293K +$279K +22,699 New
NFA
73
Nationwide Fund Advisors
Ohio
$292K +$136K +11,096 +96%
WCM
74
Wedge Capital Management
North Carolina
$290K +$9.84K +800 +4%
LBC
75
Lawrence B. Cohen
$279K

AMRI Hedge Fund Activity: Q3 2013 in Review

103 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2013, worth a combined $269M — up 18% from $228M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMRI positions and 13 closed out — a net gain of 5 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $25M. The largest seller was Systematic Financial Management, cutting an estimated $3.2M.

  • 103 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2013, up from 98 in Q2 2013.
  • Funds reported $269M of Albany Molecular Research Inc stock for Q3 2013, up 18% quarter-over-quarter.
  • 18 funds opened new Albany Molecular Research Inc positions in Q3 2013 and 13 closed out, a net change of +5 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2013 was Visium Asset Management, an estimated $25M added.
  • The largest Albany Molecular Research Inc seller in Q3 2013 was Systematic Financial Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q3 2013.